Mitochondrial DNA deletions in patients with chronic suppurative otitis media

Arzu Tatar1, Sener Tasdemir2, Ibrahim Sahin2

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Ataturk University, Erzurum, Turkey. arzutatar@atauni.edu.tr.

Insights

Mitochondrial DNA deletions, specifically the 4977 bp type, are linked to chronic suppurative otitis media and increased hearing loss. This finding suggests a potential role for mitochondrial DNA deletions in disease progression and hearing impairment.

Area of Science:

  • Genetics
  • Otolaryngology
  • Mitochondrial Biology

Background:

  • Chronic suppurative otitis media (CSOM) is a common ear infection.
  • Mitochondrial DNA (mtDNA) deletions are implicated in various cellular dysfunctions.
  • The association between mtDNA deletions and CSOM requires further investigation.

Purpose of the Study:

  • To investigate the presence of 4977 bp and 7400 bp mitochondrial DNA deletions in patients with CSOM.
  • To determine the potential association between these mtDNA deletions and the pathogenesis of CSOM.

Main Methods:

  • DNA was extracted from middle ear tissues and peripheral blood of 36 CSOM patients.
  • Polymerase chain reaction (PCR) was used to detect specific mtDNA deletions (4977 bp and 7400 bp).
  • Middle ear tissues and peripheral blood samples were analyzed for mtDNA deletions.

Main Results:

  • The 4977 bp mtDNA deletion was found in the middle ear tissue of 17 out of 36 patients, but not in their peripheral blood.
  • No patients exhibited the 7400 bp mtDNA deletion in either tissue type.
  • Patients with the 4977 bp deletion showed a longer duration of CSOM and higher levels of hearing loss (p < 0.01).

Conclusions:

  • The 4977 bp mtDNA deletion is associated with chronic suppurative otitis media.
  • This deletion may be a predisposing factor for sensorineural hearing loss in CSOM patients.
  • Antioxidant therapies could be considered for managing long-term CSOM and associated hearing loss.